Total Clarity Wealth Management, Inc. Exagen Inc. Transaction History

Total Clarity Wealth Management, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 29, 2022	SELL	$7.12 - $11.06 $12,267 - $19,056	-1,723 Closed	0 $0
Q4 2021 Feb 03, 2022	BUY	$8.97 - $14.08 $1,417 - $2,224	158 Added 10.1%	1,723 $20,000
Q3 2021 Oct 21, 2021	BUY	$10.25 - $15.21 $16,041 - $23,803	1,565 New	1,565 $21,000
Q2 2021 Jul 26, 2021	SELL	$12.4 - $17.92 $4,687 - $6,773	-378 Closed	0 $0
Q1 2021 May 05, 2021	BUY	$13.9 - $22.0 $5,254 - $8,316	378 New	378 $7,000

6.41M

4.5K

400

Ticker XGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 16,260,400
Market Cap $89.8M
Description
Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...

Get notified when there are updates to the investment portfolio of Total Clarity Wealth Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Total Clarity Wealth Management, Inc. with notifications on news.